Funder
Australian Research Council
Medical Research Future Fund
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine,Biochemistry
Reference45 articles.
1. Goh ET, Stokes CS, Sidhu SS, Vilstrup H, Gluud LL (2018) Morgan MY L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis. Cochrane Database Syst Rev 5:CD012410
2. Kircheis G, Wettstein M, Vom Dahl S, Häussinger D (2002) Clinical efficacy of L-ornithine–L-aspartate in the management of hepatic encephalopathy. Metab Brain Dis 17:453–462
3. Butterworth RF (2019) Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysis. Metab. Brain Dis. 35:75–81
4. Rose C, Michalak A, Rao KV, Quack G, Kircheis G, Butterworth RF (1999) L-Ornithine-L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology 30:636–640
5. O’Kane RL, Vina JR, Simpson I, Zaragoza R, Mokashi A, Hawkins RA (2006) Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+. Am J Physiol Endocrinol Metab 291:E412–E419
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献